The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Iden, Marissa ^a   Fye, Samantha ^a   Li, Keguo ^a   Chowdhury, Tamjid ^a   Ramchandran, Ramani ^a   Rader, Janet S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; LONG UNTRANSLATED RNA; MYC PROTEIN; NUCLEOLIN; SMALL INTERFERING RNA; MYC PROTEIN, HUMAN; PHOSPHOPROTEIN; PVT1 LONG-NON-CODING RNA, HUMAN; RNA BINDING PROTEIN;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; OVERALL SURVIVAL; PHENOTYPE; POLYMERASE CHAIN REACTION; PVT1 GENE; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; TUMOR INVASION; UPREGULATION; UTERINE CERVIX CANCER; CELL MOTION; DRUG RESISTANCE; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHOPROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, LONG NONCODING; RNA-BINDING PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84971607454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156274     Document Type: Article

References (48)

1. Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1: 391-407. doi: 10.1158/2159-8290.CD-11-0209 PMID: 22096659
2. TCGA Research Network.
3. Cory S, Graham M, Webb E, Corcoran L, Adams JM (1985) Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J 4: 675-681. PMID: 3924592
4. Webb E, Adams JM, Cory S (1984) Variant (6; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene. Nature 312: 777-779. PMID: 6440031
5. Graham M, Adams JM (1986) Chromosome 8 breakpoint far 3' of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J 5: 2845-2851. PMID: 3024964
6. Shtivelman E, Bishop JM (1990) Effects of translocations on transcription from PVT. Mol Cell Biol 10: 1835-1839. PMID: 2181290
7. Huppi K, Siwarski D (1994) Chimeric transcripts with an open reading frame are generated as a result of translocation to the Pvt-1 region in mouse B-cell tumors. Int J Cancer 59: 848-851. PMID: 7989128
8. Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, et al. (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755. PMID: 17908964
9. Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, et al. (2012) p53-Dependent induction of PVT1 and miR-1204. J Biol Chem 287: 2509-2519. doi: 10.1074/jbc.M111.322875 PMID: 22110125
10. Ding J, Li D, Gong M, Wang J, Huang X, et al. (2014) Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther 7: 1625-1630. doi: 10.2147/OTT.S68854 PMID: 25258543
11. Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, et al. (2014) Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol 7: 6929-6935. PMID: 25400777
12. Ding C, Yang Z, Lv Z, Du C, Xiao H, et al. (2015) Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett 9: 955-963. PMID: 25624916
13. Huang CS, Yu W, Cui H, Wang YJ, Zhang L, et al. (2015) Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients. Minerva Med.
14. Paci P, Colombo T, Farina L (2014) Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. BMC Syst Biol 8: 83. doi: 10.1186/1752-0509-8-83 PMID: 25033876
15. Haverty PM, Hon LS, Kaminker JS, Chant J, Zhang Z (2009) High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors. BMC Med Genomics 2: 21. doi: 10.1186/1755-8794-2-21 PMID: 19419571
16. Chapman MH, Tidswell R, Dooley JS, Sandanayake NS, Cerec V, et al. (2012) Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. J Hepatol 56: 877-885. doi: 10.1016/j.jhep.2011.10.022 PMID: 22173169
17. Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, et al. (2014) Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60: 1278-1290. doi: 10.1002/hep.27239 PMID: 25043274
18. Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, et al. (2014) Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110: 164-171. doi: 10.1038/bjc.2013.698 PMID: 24196785
19. Tseng YY, Moriarity BS, Gong W, Akiyama R, Tiwari A, et al. (2014) PVT1 dependence in cancer with MYC copy-number increase. Nature 512: 82-86. doi: 10.1038/nature13311 PMID: 25043044
20. Kong R, Zhang EB, Yin DD, You LH, Xu TP, et al. (2015) Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer 14: 82. doi: 10.1186/s12943-015-0355-8 PMID: 25890171
21. Zhou Q, Chen J, Feng J, Wang J (2015) Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumour Biol.
22. Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E (2013) The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 4: 2513. doi: 10.1038/ncomms3513 PMID: 24085110
23. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, et al. (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506: 371-375. doi: 10.1038/nature12881 PMID: 24390348
24. Iden M, Fye, S., Huang, Y., Liu, P, Rader, J.S. (2014) HPV integration and methylation patterns in cervical intraepithelial neoplasia and invasive cervical cancer via HPV capture and high-throughput sequencing [abstract]. Annual Meeting of the American Association for Cancer Research. San Diego, CA: AACR.
25. Riquelme E, Suraokar MB, Rodriguez J, Mino B, Lin HY, et al. (2014) Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma. J Thorac Oncol 9: 998-1007. doi: 10.1097/JTO.0000000000000202 PMID: 24926545
26. Zhang XW, Bu P, Liu L, Zhang XZ, Li J (2015) Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Biochem Biophys Res Commun.
27. Cunningham F, Amode MR, Barrell D, Beal K, Billis K, et al. (2015) Ensembl 2015. Nucleic Acids Res 43: D662-669. doi: 10.1093/nar/gku1010 PMID: 25352552
28. Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO (2013) Cell-type specific features of circular RNA expression. PLoS Genet 9: e1003777. doi: 10.1371/journal.pgen.1003777 PMID: 24039610
29. Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, et al. (2008) Pvt1-encoded microRNAs in oncogenesis. Retrovirology 5: 4. doi: 10.1186/1742-4690-5-4 PMID: 18194563
30. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905. doi: 10.1038/nature08822 PMID: 20164920
31. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016. PMID: 10378696
32. Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, et al. (2007) The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol 213: 511-518. PMID: 17503467
33. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2: 401-404. doi: 10.1158/2159-8290.CD-12-0095 PMID: 22588877
34. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6: pl1. doi: 10.1126/scisignal.2004088 PMID: 23550210
35. Berger CM, Gaume X, Bouvet P (2015) The roles of nucleolin subcellular localization in cancer. Biochimie 113: 78-85. doi: 10.1016/j.biochi.2015.03.023 PMID: 25866190
36. Abdelmohsen K, Gorospe M (2012) RNA-binding protein nucleolin in disease. RNA Biol 9: 799-808. doi: 10.4161/rna.19718 PMID: 22617883
37. Borer RA, Lehner CF, Eppenberger HM, Nigg EA (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379-390. PMID: 2914325
38. Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and functions of nucleolin. J Cell Sci 112 (Pt 6): 761-772. PMID: 10036227
39. Tuteja R, Tuteja N (1998) Nucleolin: a multifunctional major nucleolar phosphoprotein. Crit Rev Biochem Mol Biol 33: 407-436. PMID: 9918513
40. Zhao Y, Chen XQ, Du JZ (2009) Cellular adaptation to hypoxia and p53 transcription regulation. J Zhejiang Univ Sci B 10: 404-410. doi: 10.1631/jzus.B0820293 PMID: 19434769
41. Yang C, Maiguel DA, Carrier F (2002) Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins. Nucleic Acids Res 30: 2251-2260. PMID: 12000845
42. Daniely Y, Dimitrova DD, Borowiec JA (2002) Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol 22: 6014-6022. PMID: 12138209
43. Hiscox JA (2007) RNA viruses: hijacking the dynamic nucleolus. Nat Rev Microbiol 5: 119-127. PMID: 17224921
44. Rofstad EK, Sundfor K, Lyng H, Trope CG (2000) Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 83: 354-359. PMID: 10917551
45. Sundfor K, Lyng H, Trope CG, Rofstad EK (2000) Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 54: 101-107. PMID: 10699471
46. Hockel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG (1993) Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 51: 141-149. PMID: 8276286
47. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, et al. (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48: 149-156. PMID: 9783886
48. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110: 525-541.